227 related articles for article (PubMed ID: 11576931)
1. Association of endothelial dysfunction with sulfur amino acid metabolism in chronic renal failure.
Takamitsu Y; Nakanishi T
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S95-9. PubMed ID: 11576931
[TBL] [Abstract][Full Text] [Related]
2. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure?
Thambyrajah J; Landray MJ; McGlynn FJ; Jones HJ; Wheeler DC; Townend JN
Circulation; 2000 Aug; 102(8):871-5. PubMed ID: 10952955
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction.
van Guldener C; Stehouwer CD
Semin Thromb Hemost; 2000; 26(3):281-9. PubMed ID: 11011845
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine and renal disease.
van Guldener C; Robinson K
Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction in patients with kidney failure and vascular risk factors: acute effects of hemodialysis.
Migliacci R; Falcinelli F; Imperiali P; Floridi A; Nenci GG; Gresele P
Ital Heart J; 2004 May; 5(5):371-7. PubMed ID: 15185901
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine and endothelial function in human studies.
Moat SJ; McDowell IF
Semin Vasc Med; 2005 May; 5(2):172-82. PubMed ID: 16047269
[TBL] [Abstract][Full Text] [Related]
7. Is folate a promising agent in the prevention and treatment of cardiovascular disease in patients with renal failure?
De Vriese AS; Verbeke F; Schrijvers BF; Lameire NH
Kidney Int; 2002 Apr; 61(4):1199-209. PubMed ID: 11918726
[TBL] [Abstract][Full Text] [Related]
8. Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients.
Massy ZA; Ceballos I; Chadefaux-Vekemens B; Nguyen-Khoa T; Descamps-Latscha B; Drüeke TB; Jungers P
Kidney Int Suppl; 2001 Feb; 78():S243-5. PubMed ID: 11169019
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived hyperpolarizing factor-mediated renal vasodilatory response is impaired during acute and chronic hyperhomocysteinemia.
De Vriese AS; Blom HJ; Heil SG; Mortier S; Kluijtmans LA; Van de Voorde J; Lameire NH
Circulation; 2004 May; 109(19):2331-6. PubMed ID: 15117854
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine-Induced Endothelial Dysfunction.
Lai WK; Kan MY
Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
[TBL] [Abstract][Full Text] [Related]
11. Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy.
van Guldener C; Janssen MJ; Lambert J; ter Wee PM; Donker AJ; Stehouwer CD
Perit Dial Int; 1998; 18(3):282-9. PubMed ID: 9663892
[TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia in end-stage renal failure.
Kes P
Acta Med Croatica; 2000; 54(4-5):175-81. PubMed ID: 11379482
[TBL] [Abstract][Full Text] [Related]
13. Impairment of vascular responses to reactive hyperemia and nitric oxide in chronic renal failure.
Nakanishi T; Ishigami Y; Otaki Y; Izumi M; Hiraoka K; Inoue T; Takamitsu Y
Nephron; 2002; 92(3):529-35. PubMed ID: 12372934
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine and atherothrombosis: diagnosis and treatment.
Handy DE; Loscalzo J
Curr Atheroscler Rep; 2003 Jul; 5(4):276-83. PubMed ID: 12793968
[TBL] [Abstract][Full Text] [Related]
15. ADMA and hyperhomocysteinemia.
Dayal S; Lentz SR
Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.
Weiss N
Curr Drug Metab; 2005 Feb; 6(1):27-36. PubMed ID: 15720205
[TBL] [Abstract][Full Text] [Related]
17. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
Stanger O; Weger M
Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
[TBL] [Abstract][Full Text] [Related]
18. Hyperhomocysteinemia and atherothrombotic disease.
de Jong SC; van den Berg M; Rauwerda JA; Stehouwer CD
Semin Thromb Hemost; 1998; 24(4):381-5. PubMed ID: 9763355
[TBL] [Abstract][Full Text] [Related]
19. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
Weiss N; Keller C; Hoffmann U; Loscalzo J
Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
[TBL] [Abstract][Full Text] [Related]
20. Endothelium-dependent vasodilatation is impaired in peritoneal dialysis patients.
van Guldener C; Janssen MJ; Lambert J; Steyn M; Donker AJ; Stehouwer CD
Nephrol Dial Transplant; 1998 Jul; 13(7):1782-6. PubMed ID: 9681728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
